U.S. Markets closed

Teva Stock Has Crumbled, and Chairman Sol Barer Is Buying Up Shares

Ed Lin

The generic-drugs maker’s shares have been under pressure this year and are now trading where they were in 2000. Teva Chairman Sol Barer, a former Celgene CEO, just made his first open-market purchase as in insider.